Chronic Obstructive Pulmonary Disease (COPD)

Reimbursement: Up to £2,425, plus transport or reasonable travel expenses will be provided based on completed visits.

About This clinical research study

Chronic Obstructive Pulmonary Disease, or COPD, is a group of lung diseases including emphysematous lung disease (pulmonary emphysema) and chronic bronchitis. COPD symptoms include COPD wheezing, COPD cough, persistent chest infection and chronic breathing issues. Without treatment it is a chronic and progressive lung disease. There are times when symptoms suddenly worsen, known as COPD exacerbation or COPD flare up.

There is currently no cure for chronic bronchitis or emphysema, and the main COPD causes include
smoking and other lung irritants, but COPD treatment can help slow COPD progression. Chronic obstructive pulmonary treatment usually includes inhalers, most commonly LABA, LAMA or ICS inhalers. COPD and smoking are strongly linked, quitting smoking or vaping can help slow chronic pulmonary disease symptoms.

If you have a COPD diagnosis for 12 months or longer you may be interested in this clinical research opportunity running at MAC Clinical Research

Reimbursement: Up to £2,425, plus transport or reasonable travel expenses will be provided based on completed visits.

Clinics

Lancashire, South Staffordshire, South Yorkshire and West Yorkshire

Therapy Area

Lung Disease

Gender and Age

Males and Females aged 40 - 75

A full description of the clinical trial will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS).

There is no obligation to take part in a clinical trial and you are free to withdraw at any time.

This COPD clinical trial will evaluate the investigational medicine in people living with COPD, it is a placebo (a “dummy” medicine with no active ingredient) controlled trial with a 67% chance of receiving the investigational medicine and a 33% chance of receiving placebo. There is no guarantee you will receive benefit from your COPD disease symptoms but by participating you may help find future treatments.

The trial could last up to 52 weeks and would include at least 17 outpatient visits to the clinic over the entire trial period.

Reimbursement: Up to £2,425, plus transport or reasonable travel expenses will be provided based on completed visits.

Key Inclusion Criteria

Key Exclusion Criteria

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible participants will receive a comprehensive health screen and study participation will be in collaboration with the participant’s treating medic.

ABOUT CLINICAL RESEARCH STUDIES

Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.

If the study is successful, it may be an important step towards developing a promising new treatment.

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for COPD.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • (You can enter any supporting information here)
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Facebook
Twitter
WhatsApp
Email